Antonia Kalushkova Nair
- E-post:
- antonia.kalushkova@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
Publikationer
Senaste publikationer
Ingår i Haematologica, s. 567-577, 2024
- DOI för PVT1 interacts with the polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma
- Ladda ner fulltext (pdf) av PVT1 interacts with the polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma
The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma
Ingår i Frontiers in Oncology, 2023
- DOI för The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma
- Ladda ner fulltext (pdf) av The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Ingår i Cancer Research, s. 4586-4603, 2022
- DOI för Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- Ladda ner fulltext (pdf) av Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Ingår i EPIGENOMES, 2021
- DOI för One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies
- Ladda ner fulltext (pdf) av One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies
A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
Ingår i Cell Death and Disease, 2021
- DOI för A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
- Ladda ner fulltext (pdf) av A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
Alla publikationer
Artiklar i tidskrift
Ingår i Haematologica, s. 567-577, 2024
- DOI för PVT1 interacts with the polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma
- Ladda ner fulltext (pdf) av PVT1 interacts with the polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Ingår i Cancer Research, s. 4586-4603, 2022
- DOI för Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- Ladda ner fulltext (pdf) av Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Ingår i EPIGENOMES, 2021
- DOI för One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies
- Ladda ner fulltext (pdf) av One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies
A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
Ingår i Cell Death and Disease, 2021
- DOI för A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
- Ladda ner fulltext (pdf) av A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
GMYC: A Novel Inducible Transgenic Model of Group 3 Medulloblastoma
Ingår i Neuro-Oncology, s. 137-137, 2018
Ingår i Oncotarget, s. 10213-10224, 2017
- DOI för EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.
- Ladda ner fulltext (pdf) av EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.
Ingår i Oncotarget, s. 103731-103743, 2017
- DOI för The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomain
- Ladda ner fulltext (pdf) av The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomain
Ingår i Oncotarget, s. 6809-6923, 2016
A Role for the Chromatin-Remodeling Factor BAZ1A in Neurodevelopment
Ingår i Human Mutation, s. 964-975, 2016
- DOI för A Role for the Chromatin-Remodeling Factor BAZ1A in Neurodevelopment
- Ladda ner fulltext (pdf) av A Role for the Chromatin-Remodeling Factor BAZ1A in Neurodevelopment
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
Ingår i Journal of Experimental Medicine, s. 833-843, 2015
- DOI för Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
- Ladda ner fulltext (pdf) av Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
Ingår i Blood, 2014
Ingår i Biochemical Pharmacology, s. 284-291, 2014
- DOI för AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia
- Ladda ner fulltext (pdf) av AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia
Ingår i Blood, 2014
Dormant SOX9-positive cells behind MYC-driven medulloblastoma recurrence
Artiklar, forskningsöversikt
The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma
Ingår i Frontiers in Oncology, 2023
- DOI för The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma
- Ladda ner fulltext (pdf) av The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma